Evidence map›Paper›PMID 25296192›Full record

ArticleBioscience reports2014

GPKOW is essential for pre-mRNA splicing in vitro and suppresses splicing defect caused by dominant-negative DHX16 mutation in vivo.

Shengbing Zang, Ting-Yu Lin, Xinji Chen, Marieta Gencheva, Alain N S Newo, Lixin Yang, Daniel Rossi, Jianda Hu, Shwu-Bin Lin, Aimin Huang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. C-terminal frameshift variants in GPKOW are associated with a multisystemic X-linked disorder.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  4. Article
  5. Article
  6. Dysfunction of Gpl1-Gih35-Wdr83 Complex inInternational journal of molecular sciences · 2024
    Article
  7. Regulation of the DEAH/RHA helicase Prp43 by the G-patch factor Pfa1.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Article
  10. Structural basis for DEAH-helicase activation by G-patch proteins.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Shengbing Zang*Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope, Duarte, California, U.S.A.
Ting-Yu Lin*Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope, Duarte, California, U.S.A.
Xinji Chen*Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope, Duarte, California, U.S.A.
Marieta Gencheva*Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope, Duarte, California, U.S.A.
Alain N S Newo*Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope, Duarte, California, U.S.A.
Lixin Yang*Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope, Duarte, California, U.S.A.
Daniel Rossi*Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope, Duarte, California, U.S.A.
Jianda Hu§Fujian Institute of Hematology, Union Hospital of Fujian Medical University, Fuzhou, China.
Shwu-Bin Lin‡Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, Taiwan.
Aimin Huang†Department of Pathology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
Ren-Jang Lin*Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope, Duarte, California, U.S.A.
Fujian Medical University · CNNational Taiwan University · TWUnion Hospital · CN

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3M
NCI NIH HHS P30 CA033572
6 · The paper itself

Abstract

Human GPKOW [G-patch (glycine-rich) domain and KOW (Kyrpides, Ouzounis and Woese) domain] protein contains a G-patch domain and two KOW domains, and is a homologue of Arabidopsis MOS2 and Saccharomyces Spp2 protein. GPKOW is found in the human spliceosome, but its role in pre-mRNA splicing remains to be elucidated. In this report, we showed that GPKOW interacted directly with the DHX16/hPRP2 and with RNA. Immuno-depletion of GPKOW from HeLa nuclear extracts resulted in an inactive spliceosome that still bound DHX16. Adding back recombinant GPKOW restored splicing to the depleted extract. In vivo, overexpression of GPKOW partially suppressed the splicing defect observed in dominant-negative DHX16 mutant expressing cells. Mutations at the G-patch domain greatly diminished the GPKOW-DHX16 interaction; however, the mutant was active in splicing and was able to suppress splicing defect. Mutations at the KOW1 domain slightly altered the GPKOW-RNA interaction, but the mutant was less functional in vitro and in vivo. Our results indicated that GPKOW can functionally impact DHX16 but that interaction between the proteins is not required for this activity.

Indexed as

MutationRNA SplicingBinding SitesBlotting, WesternElectrophoretic Mobility Shift AssayHEK293 CellsHeLa CellsHumansProtein BindingRNARNA-Binding ProteinsRNA HelicasesRNA PrecursorsSpliceosomesTwo-Hybrid System TechniquesDHX16 protein, humanGPKOW protein, humanRNARNA-Binding ProteinsRNA HelicasesRNA Precursors

Identifiers

PMID25296192
PMCPMC4266926
OpenAlexW1987951727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.